ZOTIDE
Brand Name: ZOTIDE
Manufacturer: Cipla
Composition: Teriparatide Injection I.P. (750 mcg / 3 ml)
Product Type: Recombinant Human Parathyroid Hormone (rPTH 1-34)
Product Description
Medical Info
Zotide (Teriparatide Injection I.P.) is a specialized prescription medication used to treat osteoporosis in individuals at high risk for bone fractures. Manufactured by Cipla, this treatment contains recombinant human parathyroid hormone (rPTH 1-34) at a concentration of 750 mcg per 3 ml. Unlike other therapies that only slow bone loss, Zotide works as an anabolic agent, actively stimulating the body to build new, healthy bone tissue. This process increases bone mineral density and significantly reduces the risk of future fractures in the spine and hips. The medication is supplied in a pre-filled cartridge and is intended only for subcutaneous injection as directed by a healthcare professional.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
